Skip to content

Clinical trials

Completed Observational Metabolism, Inborn Errors trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Phase: Observational Status: Completed Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20121
20131
20141
20171
20182
20194
20201
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)6
University of Lausanne3
National Human Genome Research Institute (NHGRI)2
Aga Khan University Hospital, Pakistan1
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Amicus Therapeutics1
CENTOGENE GmbH Rostock1
Duke University1
Emma Marie Caroline Slack1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors24
Genetic Diseases, Inborn7
Rare Diseases6
Metabolic Diseases4
Lysosomal Storage Diseases3
Amino Acid Metabolism, Inborn Errors2
Phenylketonurias2
Porphyrias2
Propionic Acidemia2
Sphingolipidoses2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.